EUVIMEDEUVIMED entdecken
Crossref

Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways

Guangjian Fan, Juan Jin, Jie Wang, Jingxuan Xu, Weiyu Ge, Suling Liu, Lei Tang, Wumaier Reziya, Xiaoyi Yang, Junjian Li, Lai Guan Ng, Lijun Di und 14 weitere

Cancer Cell · 2026

DOI: 10.1016/j.ccell.2026.04.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Guangjian Fan und 25 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20080, Chi…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Extracellular Vesicles, Triple Negative Breast Neoplasms, Tumor Escape. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Fudan University, Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor cells evade anti-tumor immunity by reprogramming tumor microenvironment (TME). Using multiplexed single-cell proteomics to analyze 50 TME-associated proteins across treatment-naive triple-negative breast cancer (TNBC) specimens, we discovered that cancer stem cells (CSCs) drive differentiation and expansion of regulatory T cells (Tregs) via extracellular vesicle (EV)-mediated paracrine signaling. TSPAN8, an integral membrane protein on CSC-derived EVs, interacts with CD103 (integrin αEβ7) on T cells, triggering the formation of LKB1-STRAD-MO25 complex and sequential phosphorylation of LKB1 and AMPKα. This cascade enhances FOXP3 expression, which transactivates CD103, creating a positive feedback loop that drives clonal expansion of immunosuppressive CD103+FOXP3+ Tregs and their associated niche. This EV membrane topology-based mechanism operates independently of canonical EV cargo internalization. Neutralizing EVs-TSPAN8+ with a monoclonal antibody synergized with anti-PD-1 therapy in preclinical models, suggesting a potential approach targeting both CSCs and TME immunosuppression, particularly in TNBC subpopulation with high TSPAN8+ CSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsExtracellular VesiclesTriple Negative Breast NeoplasmsTumor EscapeHumansSignal TransductionAnimalsFemaleTumor MicroenvironmentTetraspaninsT-Lymphocytes, RegulatoryMiceAntigens, CDIntegrin alpha Chains

Stichwörter der Autor:innen

Tetraspanin-8Tregscancer stem cellscombined immunotherapyextracellular vesiclesimmunosuppressiontriple-negative breast cancer

Substanzen

TetraspaninsTSPAN8 protein, humanAntigens, CDalpha E integrinsIntegrin alpha Chains

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20080, China; Precision Research Center for Refractory Diseases, Shanghai Jiao T…
  • Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Department of Breast, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, No. 910 Hengshan Road, Shanghai, China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20080, China.
  • Department of Oncology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 21500, China.
  • Research Unit of Immune Regulation and Immune Diseases of Chinese Academy of Medical Sciences, Shanghai Jiao Tong University School of Medicine-Affiliated Renji Hospital, Shanghai 200127, China.

Förderung

  • Fudan University
  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • National Key Research and Development Program of China
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
  • Shanghai Anti-Cancer Association

Zitieren

APA

Fan, G., Jin, J., Wang, J., Xu, J., Ge, W., Liu, S., Tang, L., Reziya, W., Yang, X., Li, J., Ng, L. G., Di, L., Zheng, Y., Lan, F., Chen, S., Zhang, Y., Wang, X., Gao, D., Liu, X., …, & Wang, H. (2026). Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.04.004

Vancouver

Fan G, Jin J, Wang J, Xu J, Ge W, Liu S, et al. Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.04.004

BibTeX
@article{Fan2026,
  author = {Fan, Guangjian and Jin, Juan and Wang, Jie and Xu, Jingxuan and Ge, Weiyu and Liu, Suling and Tang, Lei and Reziya, Wumaier and Yang, Xiaoyi and Li, Junjian and Ng, Lai Guan and Di, Lijun and Zheng, Yuanting and Lan, Fei and Chen, Shizhuo and Zhang, Yan and Wang, Xin and Gao, Dong and Liu, Xindong and Sun, Haoyu and Liu, Yinbing and Li, Ting and Cao, Yiqun and Tao, Zhonghua and Liu, Wenting and Wang, Hongxia},
  title = {Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways},
  journal = {Cancer Cell},
  year = {2026},
  doi = {10.1016/j.ccell.2026.04.004}
}
Kostenlos starten →